Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Autoreactive cytotoxic T lymphocytes in human immunodeficiency virus type 1-infected subjects.

di Marzo Veronese F, Arnott D, Barnaba V, Loftus DJ, Sakaguchi K, Thompson CB, Salemi S, Mastroianni C, Sette A, Shabanowitz J, Hunt DF, Appella E.

J Exp Med. 1996 Jun 1;183(6):2509-16.

2.

Evidence for distinct contributions of heavy and light chains to restriction of antibody recognition of the HIV-1 principal neutralization determinant.

Watkins BA, Davis AE, Fiorentini S, di Marzo Veronese F, Reitz MS Jr.

J Immunol. 1996 Feb 15;156(4):1676-83.

PMID:
8568275
3.

Engineering a peptide epitope display system on filamentous bacteriophage.

Perham RN, Terry TD, Willis AE, Greenwood J, di Marzo Veronese F, Appella E.

FEMS Microbiol Rev. 1995 Aug;17(1-2):25-31. Review.

PMID:
7545410
4.

Structural mimicry and enhanced immunogenicity of peptide epitopes displayed on filamentous bacteriophage. The V3 loop of HIV-1 gp120.

di Marzo Veronese F, Willis AE, Boyer-Thompson C, Appella E, Perham RN.

J Mol Biol. 1994 Oct 21;243(2):167-72.

PMID:
7523682
5.

Loss of a neutralizing epitope by a spontaneous point mutation in the V3 loop of HIV-1 isolated from an infected laboratory worker.

di Marzo Veronese F, Reitz MS Jr, Gupta G, Robert-Guroff M, Boyer-Thompson C, Louie A, Gallo RC, Lusso P.

J Biol Chem. 1993 Dec 5;268(34):25894-901.

6.

Glycoprotein of human immunodeficiency virus type 1 synthesized in chronically infected Molt3 cells acquires heterogeneous oligosaccharide structures.

Pal R, di Marzo Veronese F, Nair BC, Rittenhouse S, Hoke G, Mumbauer S, Sarngadharan MG.

Biochem Biophys Res Commun. 1993 Nov 15;196(3):1335-42.

PMID:
8250888
7.

Viral DNA carried by human immunodeficiency virus type 1 virions.

Lori F, di Marzo Veronese F, de Vico AL, Lusso P, Reitz MS Jr, Gallo RC.

J Virol. 1992 Aug;66(8):5067-74.

8.

Delineation of immunoreactive, conserved regions in the external glycoprotein of the human immunodeficiency virus type 1.

di Marzo Veronese F, Rahman R, Pal R, Boyer C, Romano J, Kalyanaraman VS, Nair BC, Gallo RC, Sarngadharan MG.

AIDS Res Hum Retroviruses. 1992 Jun;8(6):1125-32.

PMID:
1380259
9.

Characterization of a neutralizing monoclonal antibody to the external glycoprotein of HIV-1.

Pal R, di Marzo Veronese F, Nair BC, Rahman R, Hoke G, Mumbauer SW, Sarngadharan MG.

Intervirology. 1992;34(2):86-93.

PMID:
1284059
10.

In Reply: Pseudotypes in HIV-Infected Mice.

Lusso P, Di Marzo Veronese F, Ensoli B, Franchini G, Jemma C, Derocco SE, Kalyanaraman VS, Gallo RC.

Science. 1990 Nov 23;250(4984):1153-4. No abstract available.

PMID:
17840195
11.

Expanded HIV-1 cellular tropism by phenotypic mixing with murine endogenous retroviruses.

Lusso P, di Marzo Veronese F, Ensoli B, Franchini G, Jemma C, DeRocco SE, Kalyanaraman VS, Gallo RC.

Science. 1990 Feb 16;247(4944):848-52.

PMID:
2305256
12.

In vitro cellular tropism of human B-lymphotropic virus (human herpesvirus-6).

Lusso P, Markham PD, Tschachler E, di Marzo Veronese F, Salahuddin SZ, Ablashi DV, Pahwa S, Krohn K, Gallo RC.

J Exp Med. 1988 May 1;167(5):1659-70.

13.

Risk of human immunodeficiency virus (HIV-1) infection among laboratory workers.

Weiss SH, Goedert JJ, Gartner S, Popovic M, Waters D, Markham P, di Marzo Veronese F, Gail MH, Barkley WE, Gibbons J, et al.

Science. 1988 Jan 1;239(4835):68-71.

PMID:
3336776
14.

Diverse tropism of HBLV (human herpesvirus 6)

Lusso P, Salahuddin SZ, Ablashi DV, Gallo RC, Di Marzo Veronese F, Markham PD.

Lancet. 1987 Sep 26;2(8561):743. No abstract available.

PMID:
2888966
15.

Sequential changes in antibody levels to the env and gag antigens in human immunodeficiency virus infected subjects.

Manca N, di Marzo Veronese F, Ho DD, Gallo RC, Sarngadharan MG.

Eur J Epidemiol. 1987 Jun;3(2):96-102.

PMID:
3497054
16.

Long-term inhibition of human T-lymphotropic virus type III/lymphadenopathy-associated virus (human immunodeficiency virus) DNA synthesis and RNA expression in T cells protected by 2',3'-dideoxynucleosides in vitro.

Mitsuya H, Jarrett RF, Matsukura M, Di Marzo Veronese F, DeVico AL, Sarngadharan MG, Johns DG, Reitz MS, Broder S.

Proc Natl Acad Sci U S A. 1987 Apr;84(7):2033-7.

17.

HTLV-I infection of cerebrospinal fluid T cells from patients with chronic neurologic disease.

DeFreitas E, Wroblewska Z, Maul G, Sheremata W, Ferrante P, Lavi E, Harper M, di Marzo-Veronese F, Koprowski H.

AIDS Res Hum Retroviruses. 1987 Spring;3(1):19-32.

PMID:
2887183
18.

Characterization of highly immunogenic p66/p51 as the reverse transcriptase of HTLV-III/LAV.

di Marzo Veronese F, Copeland TD, DeVico AL, Rahman R, Oroszlan S, Gallo RC, Sarngadharan MG.

Science. 1986 Mar 14;231(4743):1289-91.

PMID:
2418504
19.

Monoclonal antibodies specific for p24, the major core protein of human T-cell leukemia virus type III.

di Marzo Veronese F, Sarngadharan MG, Rahman R, Markham PD, Popovic M, Bodner AJ, Gallo RC.

Proc Natl Acad Sci U S A. 1985 Aug;82(15):5199-202.

Supplemental Content

Loading ...
Support Center